Medications

French charity attacks Gilead patent for hepatitis drug

French charity Medecins du Monde (MdM) on Tuesday said it was contesting a European patent awarded to a hepatitis drug made by US firm Gilead Sciences, arguing the treatment was too costly.

Medications

Pfizer painkiller gets longer patent protection (Update)

Drugmaker Pfizer Inc. said Tuesday that a new patent on one of its top drugs, anti-inflammatory painkiller Celebrex, extends its U.S. patent protection by 18 months, potentially bringing the company a few billion dollars ...

Medications

MSF challenges Pfizer's India vaccine patent application

Doctors Without Borders has challenged Pfizer's application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organizations.

Medications

India court blocks Bayer generic drug appeal

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

Vaccination

EU says US stand on patent virus waiver is no 'magic bullet'

European Union leaders cranked up their criticism of the U.S. call to waive COVID-19 vaccine patents Saturday, arguing the move would yield no short-term or intermediate improvement in vaccine supplies and could even have ...

Medications

Smarter prescriptions from doctors could save NHS billions

GP's could save billions of pounds for the NHS by switching patients' prescriptions from patented medicine to alternative drugs whose patent has expired, a new study shows. Researchers found that whilst some practitioners ...

page 17 from 26